Articles tagged "Kidney transplantation"

2019 American Transplant Congress
Outcomes in Preformed Donor-Specific Human Leukocyte Antibody Positive Living Kidney Transplant Recipients Desensitized with Intravenous Immunoglobulin and Rituximab
Y. kakuta¹, M. Okumi¹, T. Kanzawa¹, K. Unagami², H. Ishida², K. Tanabe¹
¹Urology, Tokyo Women's Medical University, Tokyo, Japan, ²Organ Transplant Medicine, Tokyo Women's Medical University, Tokyo, Japan
*Purpose: Donor-specific antibody (DSA) is associated with antibody-mediated rejection (ABMR) and is a significant immunologic barrier to graft and patient survival. Pre-transplant desensitization therapy has…
2019 American Transplant Congress
Outcomes of Induction Therapy with Bortezomib and High-Dose Intravenous Immunoglobulin for Kidney Transplantation with Preformed Donor-Specific Anti-Human Leukocyte Antigen Antibodies
Y. Miyauchi, T. Noda, N. Miura, T. Kikugawa, T. Saika
Department of Urology, Ehime University, Toon, Japan
*Purpose: Preformed donor-specific anti-human leukocyte antigen (HLA) antibodies (DSAs) are known to increase the risk of antibody-mediated rejection (ABMR) and graft failure. However, effective methods…
2019 American Transplant Congress
Kidney Biopsies In Hiv-negative To Hiv-positive Kidney Transplants – An Institutional Experience
V. Walavalkar¹, A. Zarinsefat², A. Urisman¹, D. Dobi¹, J. Vasquez³, P. Stock², Z. Laszik¹
¹Pathology, UCSF Medical Center, San Francisco, CA, ²Transplant Surgery, UCSF Medical Center, San Francisco, CA, ³Medicine, UCSF Medical Center, San Francisco, CA
*Purpose: Increased life expectancy in HIV+ patients has resulted in an increase in CKD leading to ESRD; and therefore renal transplantation in these individuals is…
2019 American Transplant Congress
The Outcomes of Living Donor Kidney Transplantation in Donors or Recipients with Donors’ Renal Arteriosclerotic Lesions on Preoperative Computed Tomography
Y. Miyauchi, T. Noda, N. Miura, T. Kikugawa, T. Saika
Ehime University, Toon, Japan
*Purpose: Living donor kidney transplantation is being increasingly performed with elderly donors. Such elderly donors often have arteriosclerotic lesions (AS) (Figure 1). Whether the outcomes…
2019 American Transplant Congress
Desensitization Protocols vs Kidney Paired Donation to Overcome AB0 Incompatibility and/or Donor Specific Antibodies in Living Donor Kidney Transplantation
F. Vistoli, V. Perrone, L. Gozzini, E. Kauffmann, N. Napoli, S. Iacopi, C. Lombardo, G. Amorese, U. Boggi
Pancreas and Kidney Transplantation Center, University of Pisa, Pisa, Italy
*Purpose: International guidelines indicate Living Donor Kidney Transplantation (LDKT) as the best option for ESRD patients. Immunological barriers like AB0 incompatibility (AB0i) and donor specific…
2019 American Transplant Congress
Postoperative Telemonitoring Following Kidney Transplantation: Effects on Early Hospital Readmissions and Graft Outcomes
N. Elfadawy, V. Humphreville, A. Padiyar, E. Sanchez, N. Sarabu
University hospitals of Cleveland, Cleveland, OH
*Purpose: Telemonitoring has been recently shown to improve outcomes and reduce hospital admission rate in cardiac patients. We sought to study the effect of telemonitoring…
2019 American Transplant Congress
Impact of Delayed Graft Function on Allograft Survival in DCD versus DBD Kidneys
T. Ishaque, A. B. Massie, J. Ruck, C. Holscher, J. G. Wang, D. L. Segev
Surgery, Johns Hopkins School of Medicine, Baltimore, MD
*Purpose: Several single-center studies have suggested no link between delayed graft function (DGF) and graft survival in recipients of donation after cardiac death (DCD) kidneys,…
2019 American Transplant Congress
Health Utility And Social Distress In Kidney Transplant (KT) Recipients
S. Macanovic¹, D. Li¹, B. Liao¹, I. Escudero¹, V. Shah², A. Nagee², A. Che², R. Khairalla², M. Novak³, I. Mucsi¹
¹Division of Nephrology and Multi-Organ Transplant Program, University Health Network, Toronto, ON, Canada, ²University of Western Ontario, London, ON, Canada, ³Centre for Mental Health, University Health Network, Toronto, ON, Canada
*Purpose: Preference-based measures of health-related quality of life (HRQOL) or health utility, such as the EuroQol-5D5L (EQ5), cover multiple health domains and are combined into…
2019 American Transplant Congress
Retroperitoneoscopic Native Nephrectomy in Renal Transplant Recipients with Autosomal Dominant Polycystic Kidney Disease
K. Hotta¹, D. Iwami², J. Furumido², K. Morita³, T. Tanabe⁴, T. Mochizuki⁴, H. Higuchi², N. Iwahara², T. Abe², K. Kanagawa⁴, N. Shinohara²
¹Hokkaido University Hospital, Sapporo, Japan, ²Urology, Hokkaido University Hospital, Sapporo, Japan, ³Urology, Kushiro City General Hospital, Kushiro, Japan, ⁴Urology, Asahikawa City General Hospital, Asahikawa, Japan
*Purpose: Autosomal dominant polycystic kidney disease (ADPKD) leads to end stage kidney disease (ESKD) and the need for kidney transplantation (KTX). Native nephrectomy is required…
2019 American Transplant Congress
The Crucial Role of Molecular Microscope in the Interpretation of Ambiguous Lesions Such as Banff Borderline Changes and Tubulo-Interstitial Inflammation Accompanying PVAN
D. Deborska-Materkowska¹, A. Perkowska-Ptasinska¹, M. Ciszek¹, P. F. Halloran², M. Myslak³
¹Warsaw Medical University, Warsaw, Poland, ²ATAGC, University of Alberta, Edmonton AB, AB, Canada, ³Pomeranian Medical University, Szczecin, Poland
*Purpose: Anti-rejection treatment implementation is highly dependent on morphologic lesions interpretation based on Banff classification. Unfortunately, some light microscopic phenotypes are ambiguous which constricts the…